CVS Group PLC
CVSG
ISIN GB00B2863827 / Valor 3457960
CVS Group PLC
UMushroom community rating:
About company
CVS Group PLC is a prominent provider of veterinary services operating primarily in the United Kingdom and Australia. Listed on the Alternative Investment Market (AIM) of the London Stock Exchange, the company manages a network of veterinary clinics that offer a range of medical and surgical services for companion animals. In addition to its clinical operations, CVS Group administers pet insurance products under the trading name MiPet Cover, which is managed through its subsidiary, Insurance Factory Limited, authorised by the Financial Conduct Authority. This integrated approach allows CVS Group to offer comprehensive care and financial protection solutions for pet owners, positioning the company as a key player in the veterinary and pet insurance sectors.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (15.10.2025):
CVS Group PLC reported its interim financial results for the first half of 2025, demonstrating a 6.6% increase in revenue to £341.8 million compared to the same period last year. While adjusted EBITDA saw a modest rise, profitability before tax declined significantly due to increased financial expenses and exceptional costs. The company's strategic investments in Australia continue to support growth, despite challenges in the UK market.
Revenue Growth
Revenue from continuing operations rose by 6.6% to £341.8 million in H1 2025, up from £320.5 million in H1 2024, reflecting ongoing expansion and market performance.
Adjusted EBITDA
Adjusted EBITDA increased by 4.5% to £67.4 million, compared to £64.5 million in the previous year, underpinned by growth from acquisitions in Australia despite inflationary pressures.
Profit Before Tax
Profit before tax on continuing operations decreased by 35.1% to £17.4 million from £26.8 million in H1 2024, primarily due to higher finance expenses, increased depreciation and amortisation, and exceptional costs related to the CMA process.
Leverage
Leverage increased to 1.66x from 1.54x in FY 2024, resulting from ongoing investments in Australian acquisitions and capital expenditures. However, this remains within the company's target leverage ratio of below 2.0x.
Operating Cash Conversion
Operating cash conversion improved by 7.2 percentage points to 72.0% in H1 2025, up from 64.8% in H1 2024, aligning with the Group's guidance of maintaining over 70%.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
1096 M
Market cap (USD)
261,203
Daily traded volume (Shares)
8.3 / 8.08
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
